A study in Nature Communications unveils heart cockles' evolved shell windows that act like fiber-optic cables, optimizing light for algae while blocking UV rays. This discovery could inspire new fiber-optic technologies and help mitigate climate change effects on marine life.

A Yale University study led by Nicholas Christakis reveals that gut microbiomes are more similar among friends, suggesting a network effect in microbial transmission. Conducted in remote Honduran villages, the research challenges previous notions by highlighting the role of social ties in microbiome-related health risks and benefits.

Researchers at Washington University have developed a yeast-based probiotic to deliver immunotherapy directly to gut tumors, potentially transforming gastrointestinal cancer treatments. This innovation uses Saccharomyces cerevisiae var. boulardii to safely produce and deliver immune checkpoint inhibitors, offering a promising alternative to traditional therapies.

NASA is advancing its ocean-exploration mission SWIM to deploy autonomous robots on Europa, a moon of Jupiter, to search for life. The Europa Clipper, launched in October, is due to reach Europa by 2030 for detailed investigation.

Gravitational waves detected by NANOGrav hint at a 'Dark Big Bang' potentially explaining dark matter's origins. Upcoming experiments like IPTA and SKA aim to test this revolutionary hypothesis.

A new study reveals over 10% of Ugandan children with severe malaria show resistance to artemisinin, the first such finding in Africa. This raises urgent concerns over future treatment options as resistance emerges independently on the continent.

Austrian and German scientists have uncovered key molecular mechanisms in the hippocampus crucial for memory formation. Their research on mossy fiber synapses highlights protein roles and synaptic changes, advancing our understanding of how memories are encoded.

Astronomers have mapped the universe over 11 billion years, confirming Einstein's predictions about galaxy clumping and cosmic evolution using DESI data. This study supports general relativity, while also constraining alternative gravity theories, enhancing our grasp of dark matter and dark energy.

Pyxis Oncology's investigational drug, PYX-201, shows a 50% objective response rate in heavily pretreated head and neck cancer patients, with a 100% disease control rate. Promising safety data and collaboration with Merck for combination trials with KEYTRUDA® highlight its potential in cancer therapy.

A Phase I trial of a new gene-editing therapy for transthyretin amyloidosis (ATTR) shows promising safety and efficacy. Utilizing CRISPR-Cas9, the therapy targets the liver gene to reduce transthyretin production, potentially stabilizing or improving patient conditions.